Dermatology OTC Medications Market Worth $21.31Bn,

0
55


New York, March 25, 2022 (GLOBE NEWSWIRE) — The Insight Partners published latest research study on “Dermatology OTC Medications Market Forecast to 2028 – COVID-19 Impact and Global Analysis By Product Type (Tablets and Capsules, Gels, Creams and Ointments, and Others), Route of Administration (Topical and Oral), Indication (Dermatitis, Acne, Psoriasis, Skin Bleaching, Fungal Disease, Warts, and Others), and Distribution Channel (Online Distribution and Offline Distribution)”, the global dermatology OTC medications market growth is driven by the high prevalence of skin problems and rising income of middle-class population. However, the market is likely to get impacted by inappropriate use of OTC medications.

Get Exclusive Sample Pages of Dermatology OTC Medications Market Size – COVID-19 Impact and Global Analysis with Strategic Insights at https://www.theinsightpartners.com/sample/TIPRE00010460/

Report Coverage Details
Market Size Value in US$ 15.45 Billion in 2021
Market Size Value by US$ 21.31 Billion by 2028
Growth rate CAGR of 4.7% from 2021 to 2028
Forecast Period 2021-2028
Base Year 2021
No. of Pages 279
No. Tables 273
No. of Charts & Figures 97
Historical data available Yes
Segments covered Product Type, Route of Administration, Indication, and Distribution Channel
Regional scope North America; Europe; Asia Pacific; Latin America; MEA
Country scope US, UK, Canada, Germany, France, Italy, Australia, Russia, China, Japan, South Korea, Saudi Arabia, Brazil, Argentina
Report coverage Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Dermatology OTC Medications Market: Competitive Landscape and Key Developments
Bausch Health Companies Inc.; Perrigo Company plc; Bayer AG; Viatris Inc.; Johnson and Johnson Services, Inc.; LEO Pharma A/S; GlaxoSmithKline plc.; Galderma; Dr. Reddy’s Laboratories; and Acella Pharmaceuticals, LLC are among the leading companies operating in the global dermatology OTC medications market. These players are focusing on expanding, diversifying their market presence, and acquiring a novel customer base, thereby tapping prevailing business opportunities.

Inquiry Before Buying: https://www.theinsightpartners.com/inquiry/TIPRE00010460/

In August 2020, Perrigo Company plc, a leading global provider of quality and affordable self-care products, announced that it acquired three Eastern European OTC skincare and hair loss treatment brands (Emolium, Iwostin, and Loxon) from Sanofi.

In April 2018, Sol-Gel Technologies Ltd.—a clinical-stage dermatology company focused on identifying, developing, and commercializing branded and generic topical drug products for the treatment of skin diseases—announced it has collaborated with Perrigo Israel, an affiliate of Perrigo Company plc, for the development, manufacturing, and commercialization of a generic product candidate.

In 2020, North America dominated the dermatology OTC medications market. The US holds the largest share of the market in this region. The market growth is attributed to the increase in skin abnormalities and the rise in dermatology over-the-counter (OTC) drugs in North America.

The costs of Dermatology OTC medications are highest in the US globally. It is home to the world’s leading multinational corporations, such as Perrigo Company plc, Bayer AG, Viatris Inc., Galderma, and LEO Pharma A/S. It has the most cutting-edge technology. All these factors contribute to the highest market growth in the region. Moreover, the American Academy of Dermatology (AAD) estimated that one in three American citizens visit dermatologists, and one in every four is affected by skin diseases every year. Hence, a growing need for rapid diagnosis and treatment of skin disorders is subsequently driving the dermatology OTC medications market.

Speak to Research Analyst: https://www.theinsightpartners.com/speak-to-analyst/TIPRE00010460

The dermatology OTC products approval is likely to enable the company to sell these products in the American market. Similarly, the key companies are focusing on strategic initiatives, such as mergers, acquisitions, new product development, and geographical expansions. For instance, in July 2016, Galderma received FDA approval for Differin Gel 0.1% (adapalene), a once-daily topical gel for the over-the-counter (OTC) treatment of acne, in July 2016. Differin Gel 0.1% is licensed for usage in people aged 12 and above. Thus, the dermatology OTC medications market is estimated to grow significantly during the forecast period due to these factors.

As per European Union, the middle-class population is expected to reach 5.3 billion by 2030, and the Asian population of middle-class people is likely to be at the forefront. According to the World Bank Group, by 2030, China and India are expected to represent ~66% of the global middle-class population and ~59% of middle-class consumption. With significant changes in consumer behavior and consumption patterns, the middle-class expansion will drive global economic development. In addition, the US Bureau of Labor Statistics stated that disposable income in the US increased from US$ 10,036.9 billion in 2006 to US$ 13,968.6 billion in 2016; it is further expected to reach US$ 21,178.2 billion by 2026. Increased disposable incomes and better after-care treatment have led to the growing adoption of dermatology OTC medications to treat skin conditions. Thus, a surge in the adoption rate of OTC medications supports the growth of the dermatology OTC medications market.

Dermatology OTC Medications Market: Segmental Overview
The dermatology OTC medications market is segmented into product type, route of administration, indication, and distribution channel. Based on product type, the global dermatology OTC medications market is segmented into tablets and capsules, gels, creams and ointments, and others. The creams and ointments segment held the largest share of the market in 2021. However, the tablets and capsules segment is anticipated to register the highest CAGR during the forecast period. Based on route of administration, the dermatology OTC medications market is bifurcated into topical and oral. The topical segment held a larger share of the market in 2021; however, the oral segment is estimated to register a higher CAGR during the forecast period. Based on indication, the dermatology OTC medications market is segmented into dermatitis, acne, psoriasis, skin bleaching, fungal disease, warts, and others. The acne segment held the largest share of the market in 2021; it is estimated to register the highest CAGR during the forecast period. Based on distribution channel, the dermatology OTC medications market is bifurcated into online distribution and offline distribution. The offline distribution segment held a larger share of the market in 2021; however, the online distribution segment is estimated to register a higher CAGR during the forecast period. Furthermore, the offline distribution segment is bifurcated into retail & hospital pharmacies and super & hyper markets. The retail & hospital pharmacies segment held a larger share of the market in 2021.

Buy Premium Copy of Dermatology OTC Medications Market Size, Share, Revenue, Strategic Insights and Forecasts 2021-2028 Research Report at https://www.theinsightpartners.com/buy/TIPRE00010460/

The  COVID-19  pandemic  has brought about a significant burden on the healthcare industry globally. As the world slowly recovers, the way businesses are conducted will never be the same. COVID-19 has altered the corporate landscape in general. Several companies have experienced severe losses in the last quarter of 2019 and negatively influenced the first and second quarters of 2020. Research and development activities to identify the threat of the SARS-CoV-2 virus on the patients suffering are likely to slow the dermatology OTC medication market growth. Hence, the impact of the COVID-19 pandemic on the dermatology OTC medications market was immediate and drastic. The demand for dermatology OTC medications is reduced due to the COVID-19 outbreak, as the focus of healthcare shifted toward saving lives. The COVID-19 pandemic is causing massive disruptions in global supply chains, consumer markets, and the global economy. As a result of the measures implemented by governments worldwide, there is a risk of a temporary and significant decline in demand for dermatology OTC medications. Therefore, the pandemic has adversely affected the dermatology OTC medications market.

Browse Adjoining Reports:
Dermatology OTC Drug Market Forecast to 2028 – COVID-19 Impact and Global Analysis By Indication (Dermatitis, Acne, Psoriasis, Skin Bleaching, Anti-fungal, Wart Remover, Others); Route of Administration (Topical, Oral); Distribution Channel (Online Distribution, Hospital and Retail Pharmacies, Super and Hyper Markets), and Geography

Dermal Fillers Market Forecast to 2028 – COVID-19 Impact and Global Analysis By Product (Biodegradable, and Non-Biodegradable); Material (Calcium Hydroxylapatite, Hyaluronic Acid, Collagen, Poly-L-Lactic Acid, Polymethylmethacrylate (PMMA), Fat Fillers, and Other Materials); Application (Facial Line Correction Treatment, Lip Enhancement, Face Lift, Scar Treatment, and Others); End user (Multispecialty Hospitals, Dermatology Clinics, Ambulatory Surgical Centers, and Others), and Geography

Dermatology Treatment Devices Market Forecast to 2027 – COVID-19 Impact and Global Analysis by Product Type (Lasers, Light Therapy Devices, Cryotherapy Devices, Microdermabrasion Devices, Energy-Based Therapies Devices, and Microneedling); Application (Skin Resurfacing, Skin Rejuvenation, Hair Removal, Psoriasis, Scar, Warts and Skin Tags, Hyperpigmentation and Vascular Lesions, Acne, Tattoo Removal, and Hyperhidrosis); End User (Hospitals, SPA Clinics, Dermatology Clinics, and Surgical Centers), and Geography

Dermatology Lasers Market Forecast to 2028 – Covid-19 Impact and Global Analysis – by Product (High-Flux Dialyzer and Low-Flux Dialyzer), End User (In-Center Dialysis, Home Dialysis and Others), and Geography

Skin Tightening Market Forecast to 2027 – COVID-19 Impact and Global Analysis By Product Type (Radio Frequency Skin Tightening, Laser Skin Tightening, Ultrasound Skin Tightening); Portability (Portable, Standalone); Treatment Type (Non-Invasive, Minimally Invasive); Application (Wrinkle Reduction, Face Lifting, Body Lifting, Anti-Aging, Others); End User (Dermatology Clinics, Hospitals, Beauty Salons and Cosmetic Centers, Home Care), and Geography

Skin Graft Market Forecast to 2028 – COVID-19 Impact and Global Analysis By Product (Autologous, Allogeneic, Xenogeneic, Prosthetic, and Isogeneic), Graft Thickness (Split-Thickness, Full-Thickness, and Composite Graft), Application (Burns, Extensive Wound, Skin Cancer, and Other Applications), Equipment (Dermatome, General Surgical Instruments, Consumables, and Others), and End User (Ambulatory Surgical Centers, Hospitals, and Dermatology Clinics) and Geography

Fractional Ablative Skin Resurfacing Devices Market Forecast to 2028 – Covid-19 Impact and Global Analysis – By Source (Carbon Dioxide (C02) Lasers, Erbium: Yttrium-Aluminium-Garnet (Er:YAG) Lasers); Application (Acne Scarring, Traumatic and Surgical Scars, Benign Skin Tumors, Warts, Fine Lines Or Wrinkles, Xanthelasma, Rhinophyma, Others); End-User (Dermatology Clinics, Beauty Centers and Spas, Hospitals) and Geography

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Contact Us:
If you have any queries about this report or if you would like further information, please contact us:

Contact Person: Sameer Joshi
E-mail: [email protected]
Phone: +1-646-491-9876
Press Release: https://www.theinsightpartners.com/pr/dermatology-otc-medications-market



Source link